The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Duration: November 1, 2007
to
May 31, 2017
General Issues: Health Issues , Medicare/Medicaid
Spending: about $3,140,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2007: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Treasury - Dept of, Office of Management & Budget (OMB), Y
Y
CMS
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Colin Roskey
Health Policy Adv'r & Counsel, Sen. Finance Cmte
Dan Elling
Staff Director, Ways and Means Health Subcmte
Prof. Staff, Ways and Means Health Subcmte
Health Policy Aide, Rep. Nancy Johnson
Legislative Assistant, Rep. Jim Ramstad
Carolyn Smith
Assoc. Dep. CoS & Leg. Cnsl., Joint Cmt. on Tax
Bob Siggins
Chief of Staff for Rep. Earl Pomeroy
Earl Pomeroy
U.S. Congressman for North Dakota
Danielle White
Intern, Senate HELP Committee; Intern, HHS Office of General Counsel (CMS Division); Intern, Staff Assistant and Executive Assistant, Rep. Nancy Johnson.
Stephanie Kennan
Sr. Health Policy Advisor, Sen. Ron Wyden
Sr. Health Pol. Advisor, Sen. Ron Wyden
THOMAS A. SCHULLY
n/a
MARILYN YAKER
n/a
M. LYNN SYKES
n/a
JENNIFER L. BUTLER
n/a
ERIN L. DARLING
n/a
Marc Scheineson
n/a
Timothy P. Trysla
n/a
JENNIEFER BELL
n/a
Mark Rayder
n/a
David Hebert
n/a
Rudy Missmar
n/a
Regina Sherick
n/a
Thomas Scully
n/a
Tiffani Williams
n/a
Tom Scully
n/a
Jennifer Bell
n/a
Marilyn Yager
n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2017
ALSTON & BIRD LLP terminated an engagement in which they represented KIDNEY CARE COUNCIL on July 20, 2017.
Original Filing: 300894094.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
1st Quarter, 2017
In Q1, ALSTON & BIRD LLP lobbied for KIDNEY CARE COUNCIL , earning $100,000. The report was filed on April 20, 2017.
Original Filing: 300873979.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
4th Quarter, 2016
In Q4, ALSTON & BIRD LLP lobbied for KIDNEY CARE COUNCIL , earning $100,000. The report was filed on Jan. 23, 2017.
Original Filing: 300855390.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
3rd Quarter, 2016
In Q3, ALSTON & BIRD LLP lobbied for KIDNEY CARE COUNCIL , earning $90,000. The report was filed on Oct. 20, 2016.
Original Filing: 300836137.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The ESRD Choice Act (H.R. 5659).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
2nd Quarter, 2016
In Q2, ALSTON & BIRD LLP lobbied for KIDNEY CARE COUNCIL , earning $110,000. The report was filed on July 20, 2016.
Original Filing: 300818041.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
1st Quarter, 2016
In Q1, ALSTON & BIRD LLP lobbied for KIDNEY CARE COUNCIL , earning $110,000. The report was filed on April 20, 2016.
Original Filing: 300798879.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
4th Quarter, 2015
In Q4, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $110,000. The report was filed on Jan. 19, 2016.
Original Filing: 300775610.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2016, Final 2016 Letter to Issuers in the Federally-facilitated Marketplaces.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
3rd Quarter, 2015
In Q3, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $110,000. The report was filed on Oct. 20, 2015.
Original Filing: 300764917.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2016, Final 2016 Letter to Issuers in the Federally-facilitated Marketplaces.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
2nd Quarter, 2015
In Q2, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $110,000. The report was filed on July 19, 2015.
Original Filing: 300740109.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Final Rule [CMS-1526-F]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); Medicare and State Health Care Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute; and Civil Monetary Penalty Rules Regarding Beneficiary Inducements and
Gainsharing: Proposed Rule, 79 Fed. Reg. 59717 (Oct. 3, 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2016, Final 2016 Letter to Issuers in the Federally-facilitated Marketplaces.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
1st Quarter, 2015
In Q1, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $110,000. The report was filed on April 19, 2015.
Original Filing: 300721077.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Final Rule [CMS-1526-F]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); Medicare and State Health Care Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute; and Civil Monetary Penalty Rules Regarding Beneficiary Inducements and
Gainsharing: Proposed Rule, 79 Fed. Reg. 59717 (Oct. 3, 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2016, Final 2016 Letter to Issuers in the Federally-facilitated Marketplaces.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
4th Quarter, 2014
In Q4, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $110,000. The report was filed on Jan. 16, 2015.
Original Filing: 300699223.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Final Rule [CMS-1526-F]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); Medicare and State Health Care Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute; and Civil Monetary Penalty Rules Regarding Beneficiary Inducements and Gainsharing: Proposed Rule, 79 Fed. Reg. 59717 (Oct. 3, 2014).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Final Rule [CMS-1526-F]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to
Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); Medicare and State Health Care Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute; and Civil Monetary Penalty Rules Regarding Beneficiary Inducements and Gainsharing: Proposed Rule, 79 Fed. Reg. 59717 (Oct. 3, 2014).
Agencies Lobbied
U.S. Senate U.S. House of Representatives Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2014
ALSTON & BIRD, LLP amended a lobbying report for representation of KIDNEY CARE COUNCIL in Q32014 on Oct. 20, 2014.
Original Filing: 300687617.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Final Rule [CMS-1526-F]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
3rd Quarter, 2014
ALSTON & BIRD, LLP amended a lobbying report for representation of KIDNEY CARE COUNCIL in Q32014 on Oct. 20, 2014.
Original Filing: 300684948.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Final Rule [CMS-1526-F]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
3rd Quarter, 2014
In Q3, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $60,000. The report was filed on Oct. 17, 2014.
Original Filing: 300681320.xml
Lobbying Issues
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Final Rule [CMS-1526-F]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
2nd Quarter, 2014
In Q2, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $60,000. The report was filed on July 10, 2014.
Original Filing: 300654984.xml
Lobbying Issues
Protecting Access to Medicare Act of 2014 (Public Law No. 113.93); The Budget Control Act of 2011 (Pub.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Final Rule [CMS-1526-F]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit PolicyManual; Centers for Medicare & Medicaid Services,
Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; contacts with the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ESRD.
Also contacted the Center for Consumer Information & Insurance Oversight (CCIIO).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Protecting Access to Medicare Act of 2014 (Public Law No. 113.93); The Budget Control Act of 2011 (Pub.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Final Rule [CMS-1526-F];CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit PolicyManual; Centers for Medicare & Medicaid Services,
Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; contacts with the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ESRD.
Also contacted the Center for Consumer Information & Insurance Oversight (CCIIO).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2014
In Q1, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $60,000. The report was filed on April 21, 2014.
Original Filing: 300648715.xml
Lobbying Issues
Protecting Access to Medicare Act of 2014 (Public Law No. 113.93); The Budget Control Act of 2011 (Pub.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Final Rule [CMS-1526-F]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014.
Also contacted the Center for Consumer Information & Insurance Oversight (CCIIO).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
Protecting Access to Medicare Act of 2014 (Public Law No. 113.93); The Budget Control Act of 2011 (Pub.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment
System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Final Rule [CMS-1526-F];CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014.
Also contacted the Center for Consumer Information & Insurance Oversight (CCIIO).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2013
In Q4, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $50,000. The report was filed on Jan. 21, 2014.
Original Filing: 300626097.xml
Lobbying Issues
Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Bad Debt Reductions for All Medicare Providers; Proposed Rule [CMS CMS-1352-P]; The Budget Control Act of 2011 (Pub.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
3rd Quarter, 2013
In Q3, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $50,000. The report was filed on Oct. 21, 2013.
Original Filing: 300607291.xml
Lobbying Issues
Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Bad Debt Reductions for All Medicare Providers; Proposed Rule [CMS CMS-1352-P]; The Budget Control Act of 2011 (Pub.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
2nd Quarter, 2013
In Q2, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $50,000. The report was filed on July 22, 2013.
Original Filing: 300585956.xml
Lobbying Issues
The Budget Control Act of 2011 (Pub.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
1st Quarter, 2013
In Q1, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $70,000. The report was filed on April 22, 2013.
Original Filing: 300562924.xml
Lobbying Issues
CY 2013 End-Stage Renal Disease Prospective Payment System Final Rule (CMS-1352-F); the Patient Protection and Affordable Care Act; Standards Related to Essential Health Benefits, Actuarial Equivalence, and Accreditation (77 Fed. Reg. 70,644); The Budget Control Act of 2011 (Pub.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240);Medicare Program: Comprehensive End-Stage Renal Disease Care Model Announcement (CMS-5506-N).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
4th Quarter, 2012
In Q4, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $80,000. The report was filed on Jan. 22, 2013.
Original Filing: 300541871.xml
Lobbying Issues
CY 2013 End-Stage Renal Disease Prospective Payment System Final Rule (CMS-1352-F); the Patient Protection and Affordable Care Act; Standards Related to Essential Health Benefits, Actuarial Equivalence, and Accreditation (77 Fed. Reg. 70,644); The Budget Control Act of 2011 (Pub.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
3rd Quarter, 2012
In Q3, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $80,000. The report was filed on Oct. 22, 2012.
Original Filing: 300520817.xml
Lobbying Issues
HHS Final Rule on Exchange Establishment ([CMS9989F]; IRS/Treasury final rule on health insure premium credit (RIN 1545BJ82); Proposed CY 2013 End-Stage Renal Disease Prospective Payment System (CMS-1352-P); The Budget Control Act of 2011 (Pub.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
2nd Quarter, 2012
In Q2, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $80,000. The report was filed on July 20, 2012.
Original Filing: 300497697.xml
Lobbying Issues
CMS-6037-P: Medicare Program; Reporting and Returning of Overpayments: Proposed Rule; The Budget Control Act of 2011 (Pub.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Issues related to the ESRD Quality Incentive Program (QIP).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
1st Quarter, 2012
In Q1, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $80,000. The report was filed on April 20, 2012.
Original Filing: 300474243.xml
Lobbying Issues
Essential Health Benefits Bulletin, released by the Consumer Information and Insurance Oversight (CCIIO) on December 16, 2011; The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
CMS-9070-P: Medicare and Medicaid Program; Regulatory Provisions to Promote Program Efficiency, Transparency, and Burden Reduction: Proposed Rule; Agency Information Collection: Independent Renal Dialysis Facility Cost Report; Document Identifier CMS-265-11 (Notice); Health Insurance Premium Tax Credit Regulation (REG 131491-10); Patient Protection and Affordable Care Act; Establishment of Exchanges and Qualified Health Plans; Proposed rule [CMS-9989-P].
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2011
In Q4, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $80,000. The report was filed on Jan. 20, 2012.
Original Filing: 300452713.xml
Lobbying Issues
CMS-9070-P: Medicare and Medicaid Program; Regulatory Provisions to Promote Program Efficiency, Transparency, and Burden Reduction: Proposed Rule; Agency Information Collection: Independent Renal Dialysis Facility Cost Report; Document Identifier CMS-265-11 (Notice); Health Insurance Premium Tax Credit Regulation (REG 131491-10); Patient Protection and Affordable Care Act; Establishment of Exchanges and Qualified Health Plans; Proposed rule [CMS-9989-P].
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Medicare/Medicaid Health Issues
3rd Quarter, 2011
In Q3, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $80,000. The report was filed on Oct. 20, 2011.
Original Filing: 300429098.xml
Lobbying Issues
The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Medicare Program; Changes to the End-Stage Renal Disease Prospective Payment System for CY 2012, End-Stage Renal Disease Quality Incentive Program for PY 2013 and PY 2014; Proposed Rule (CMS-1577-P); Patient Protection and Affordable Care Act; Establishment of Exchanges and Qualified Health Plans, and Standards Related to Reinsurance, Risk Corridors and Risk Adjustment; Extension of Comment Period [CMS-9989-N2]; Patient Protection and Affordable Care Act; Exchange Functions in the Individual Market: Eligibility Determinations; Exchange Standards for Employers: Proposed Rule [CMS-9974-P]; Health Insurance Premium Tax Credits: Proposed Rule (REG-131491-10).
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Medicare/Medicaid Health Issues
2nd Quarter, 2011
In Q2, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $80,000. The report was filed on July 20, 2011.
Original Filing: 300405774.xml
Lobbying Issues
The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Changes to the ESRD Prospective Payment System Transition Budget Neutrality Adjustment (CMS-1435-IFC); Request for Comments Regarding Exchange-Related Provisions in Title 1 of the Patient Protection and Affordable Care Act (OCIIO-99890NC); (CSM-1345-NC); Institute of Medicine, Consensus Study, Determination of Essential Health Benefits.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
The Patient Protection and Affordable Care Act (P.L. 111-148); the Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Medicare Program; End-Stage Renal Disease Prospective Payment System; Final Rule and Proposed Rule (CMS-1418-F); Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for Cy 2011 Proposed Rule (CMS-1503-P).Request for Comments Regarding Exchange-Related Provisions in Title 1 of the Patient Protection and Affordable Care Act (OCIIO-99890NC); (CSM-1345-NC); Institute of Medicine, Consensus Study, Determination of Essential Health Benefits.
Agencies Lobbied
Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2011
In Q1, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $80,000. The report was filed on April 20, 2011.
Original Filing: 300380017.xml
Lobbying Issues
The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Changes to the ESRD Prospective Payment System Transition Budget Neutrality Adjustment (CMS-1435-IFC).Request for Comments Regarding Exchange-Related Provisions in Title 1 of the Patient Protection and Affordable Care Act (OCIIO-99890NC); Medicare Program; Request for Information Regarding Accountable Care Organizations and the Medicare Shared Savings Program (CSM-1345-NC); Institute of Medicine, Consensus Study, Determination of Essential Health Benefits.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Lobbying Issues
The Patient Protection and Affordable Care Act (P.L. 111-148); the Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Medicare Program; End-Stage Renal Disease Prospective Payment System; Final Rule and Proposed Rule (CMS-1418-F); Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for Cy 2011 Proposed Rule (CMS-1503-P).Request for Comments Regarding Exchange-Related Provisions in Title I of the Patient Protection Affordable Care Act (OCIIO-9989-NC); Medicare Program; Request for Information Regarding Accountable Care Organizations and the Medicare Shared Savings Program (CMS-1345-NC); Institute of Medicine, Consensus Study, Determination of Essential Health Benefits.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2010
ALSTON & BIRD, LLP amended a lobbying report for representation of KIDNEY CARE COUNCIL in Q42010 on Jan. 20, 2011.
Original Filing: 300354743.xml
Lobbying Issues
The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Medicare Program; End-Stage Renal Disease Prospective Payment System; Final Rule and Proposed Rule (CMS-1418-F); Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011 Proposed Rule (CMS-1503-P).Request for Comments Regarding Exchange-Related Provisions in Title I of the Patient Protection and Affordable Care Act (OCIIO-9989-NC); Medicare Program; Request for Information Regarding Accountable Care Organizations and the Medicare Shared Savings Program (CMS-1345-NC); Institute of Medicine, Consensus Study, Determination of Essential Health Benefits.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
3rd Quarter, 2010
ALSTON & BIRD, LLP amended a lobbying report for representation of KIDNEY CARE COUNCIL in Q32010 on Oct. 20, 2010.
Original Filing: 300329290.xml
Lobbying Issues
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Medicare Program, End-Stage Renal Disease Prospective Payment System, Proposed Rule (CMS-1418-P); Medicare Program, Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011, Proposed Rule (CMS-1503-P).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
3rd Quarter, 2010
In Q3, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $80,000. The report was filed on Oct. 20, 2010.
Original Filing: 300329070.xml
Lobbying Issues
Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Medicare Program, End-Stage Renal Disease Prospective Payment System, Proposed Rule (CMS-1418-P); Medicare Program, Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2011, Proposed Rule (CMS-1503-P).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Health Issues Medicare/Medicaid
2nd Quarter, 2010
In Q2, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $80,000. The report was filed on July 20, 2010.
Original Filing: 300303257.xml
Lobbying Issues
PL 111-148 Patient Protection and Affordable Care Act; PL 111-152 Health Care and Education Reconciliation Act of 2010; Medicare Program; End-Stage Renal Disease Prospective Payment System; Proposed Rule (CMS-1418-P); Dep't of Veterans Affairs "Payment for Inpatient and Outpatient Health Care Professional Services at Non-Departmental Facilities and Other Medical Charges Associated with Non-VA Outpatient Care" (38 CFR part 17, RIN 2900-AN37.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2010
In Q1, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $80,000. The report was filed on April 20, 2010.
Original Filing: 300274882.xml
Lobbying Issues
Senate Health Reform Bill - Patient Protection and Affordable Care Act (H.R. 3590); House Health Reform Bill -
Affordable Health Care for America Act (H.R. 3962); Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); Medicare Program; End-Stage Renal Disease Prospective Payment System; Proposed Rule (CMS-1418-P)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
4th Quarter, 2009
In Q4, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $80,000. The report was filed on Jan. 20, 2010.
Original Filing: 300247389.xml
Lobbying Issues
Senate Health Reform Bill - Patient Protection and Affordable Care Act (H.R. 3590); House Health Reform Bill - Affordable Health Care for America Act (HR. 3962); Senate Finance Committee Reform Bill - America's Healthy Future Act of 2009 (S. 1796); House Tri-Committee Reform Bill - America's Affordable Health Choices Act of 2009 (H.R. 3200); Medicare Program: End-Stage Renal Disease Prospective Payment System; Proposed Rule (CMS-1418-P); Medicare program- Town Hall Meeting on End-Stage Renal Disease Prospective Payment System (CMS-1508-N); Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2010; Final Rule (CMS-1413-FC); Medicare Program; Revisions to Payment Policies Under the Physicians Fee Schedule and Part B for CY 2010, Final Rule (CMS-14130-FC)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
3rd Quarter, 2009
In Q3, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $80,000. The report was filed on Oct. 20, 2009.
Original Filing: 300222229.xml
Lobbying Issues
America's Affordable Health Choices Act of 2009 (HR 3200); Affordable Health Choices Act (S. 1679); House Tri-Committee and Senate Finance Health Reform Proposals; Medicare Program: End-Stage Renal Disease Prospective Payment System: Proposed Rule ("CMS-1418-P"); Medicare Program; Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2010; Proposed Rule ("CMS-1413-P")
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS) Treasury - Dept of
2nd Quarter, 2009
In Q2, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $80,000. The report was filed on July 20, 2009.
Original Filing: 300188146.xml
Lobbying Issues
House and Senate Budget Resolutions (H. Con. Res. 85)
American Recover and Reinvestment Act
House and Senate health reform proposals
Affordable Health Choices Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS) Health & Human Services - Dept of (HHS) Treasury - Dept of
1st Quarter, 2009
In Q1, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $90,000. The report was filed on April 23, 2009.
Original Filing: 300166667.xml
Lobbying Issues
H.R. 1/S. 1, American Recovery and Reinvestment Act
State Children's Health Insurance Program Reauthorization
FY2010 Labor HHS Appropriations
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) Treasury - Dept of
4th Quarter, 2008
In Q4, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $90,000. The report was filed on Jan. 21, 2009.
Original Filing: 300133815.xml
Lobbying Issues
H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008, provisions related to bundled payment system reform, permanent composite rate update and dialysis education and training sessions.
Impact of Final Rule: ESRD Facility Conditions for Coverage.
Impact of Final Rule: Medicare CY 2009 Physician Fee ScheduleS. 1, Economic Recovery Stimulus
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) Office of Management & Budget (OMB)
3rd Quarter, 2008
In Q3, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $90,000. The report was filed on Oct. 20, 2008.
Original Filing: 300106737.xml
Lobbying Issues
H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008, provisions related to bundled payment system reform, permanent composite rate update and dialysis education and training sessions.
Impact of Final Rule: ESRD Facility Conditions for Coverage.H.R. 1424, The Paul Wellstone Mental and Addiction Equity Act of 2007, Section 106, Re: possible inclusion of extension of Medicare as secondary payer.
Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Part B for CY 2009; and Revisions to the Amendment of the E-Prescribing Exemption for Computer Generated Facsimile Transmissions; Proposed Rule" (CMS-1403-P, 07/07/2008) Re: Section II.H. Provisions Related to Payment for Renal Dialysis Services Furnished by End-Stage Renal Disease (ESRD) Facilities."
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS) Office of Management & Budget (OMB)
2nd Quarter, 2008
In Q2, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $90,000. The report was filed on July 21, 2008.
Original Filing: 300082847.xml
Lobbying Issues
S. 691/H.R. 1193, The Kidney Care Quality and Education Act of 2007, provisions related to a permanent composite rate update and extension of Medicare Secondary Payer policy; S. 3101, Medicare Improvements for Patients and Providers Act of 2008; S. 3118, Preserving Access to Medicare Act of 2008; H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008, provisions related to bundled payment system reform, permanent composite rate update and dialysis education and training sessions.Impact of Final Rule: ESRD Facility Conditions for Coverage
Impact of Report to Congress: A Design for a Bundled End Stage Renal Disease Prospective Payment System
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Centers For Medicare and Medicaid Services (CMS)
1st Quarter, 2008
In Q1, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $60,000. The report was filed on April 18, 2008.
Original Filing: 300045753.xml
Lobbying Issues
S. 691/H.R. 1193, The Kidney Care Quality and Education Act of 2007, provisions related to a permanent composite rate update and an extension of Medicare Secondary Payer.
Impact of the ESRD Facility Conditions for Coverage Final Rule.
A potential bundled payment system for ESRD services.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Centers For Medicare and Medicaid Services (CMS)
0th Quarter, 2007
In MM, ALSTON & BIRD, LLP lobbied for KIDNEY CARE COUNCIL , earning $180,000. The report was filed on Aug. 6, 2007.
Original Filing: 200046925.xml
Lobbying Issues
Kidney Health legislation, health information technology legislation, dialysis composite rates
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate